Business Standard

Shreehas Tambe elevated as MD & CEO of Biocon Biologics effective Monday

He was earlier the firm's deputy CEO; Outgoing MD Arun Chandavarkar to remain on co Board

SAT stays Biocon insider trading order
Premium

Sohini Das Mumbai
Biocon Biologics has elevated deputy CEO Shreehas Tambe as its Managing Director and CEO effective Monday, the company said.

Tambe takes over from Arun Chandavarkar, who will continue as non-executive, non-independent director on the firm's board.

Tambe has been with Biocon since 1997, and has helped shape and build its biosimilars business and spearheaded the group’s strategic capital investments, including its first overseas facility in Malaysia.

“He has also been instrumental in securing regulatory approvals and enabling the successful launch of several of the company’s biosimilar assets in global markets such as the US and EU,” the company said.

Kiran

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in